Multidisciplinary Approach to Hemodynamic Management During High-Risk Ventricular Tachycardia Ablation
Aditya Bharadwaj1, Melissa D McCabe2, Tahmeed Contractor1
1Division of Cardiology, Department of Medicine, Loma Linda University, Loma Linda, California, USA.
JACC. Case Reports
|June 9, 2022
Summary
High-risk ventricular tachycardia ablation may require percutaneous ventricular assist devices for hemodynamic support. This study details a coordinated, team-based approach for managing these complex patients during procedures.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Technology
Background:
- High-risk ventricular tachycardia (VT) ablation poses significant hemodynamic challenges.
- Percutaneous ventricular assist devices (PVADs) are utilized in cases of expected hemodynamic decompensation during VT ablation.
Observation:
- A case example illustrates the application of PVADs in managing a patient with high-risk VT.
- The study focuses on the development and implementation of a coordinated, team-based approach.
Findings:
- A structured, multidisciplinary approach enhances periprocedural patient management.
- Effective coordination is crucial for optimizing outcomes in complex VT ablation cases.
Implications:
- This approach can serve as a model for centers performing high-risk VT ablation.
- Improved patient outcomes are anticipated through standardized, team-based periprocedural care.
- Highlights the critical role of PVADs and coordinated care in advanced cardiac procedures.
Keywords:
AHD, acute hemodynamic decompensationCPO, cardiac power outputHR-VTA, high-risk ventricular tachycardia ablationICD, implantable cardioverter-defibrillatorLV, left ventricularMCS, mechanical circulatory supportSVO2, mixed venous oxygen saturationVT, ventricular tachycardiaVTA, ventricular tachycardia ablationablationhemodynamicsmultidisciplinary carepVAD, percutaneous ventricular assist devicepercutaneous mechanical circulatory supportventricular tachycardiaMore Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.6K
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
969
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
115
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
115
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
86
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
86
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
177
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
177
01:29Cardiomyopathy V: Interprofessional Care
42
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
42
01:22Heart Failure VI: Adjunct Therapies
40
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
40
01:17Increased pulse rate
763
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
763